Clofarabine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Clofarabine. Educational only — not medical advice.

Labeled uses

Clofarabine injection is indicated for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens.

Source: FDA labeling via NIH DailyMed (set 26b2de66…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.